We determined the cost of care for 2 diagnosis and management approaches for acute otitis media (AOM) among children 6 to 30 months old. A case-control design was used. Cases included 208 children diagnosed with AOM based on a bulging tympanic membrane (TM) and treated with amoxicillin/clavulanate. Controls (5:1 ratio) included 1020 children with AOM diagnosed not requiring bulging of the TM and treated with amoxicillin. Fewer cases (49%) than controls (69%) were diagnosed with AOM (P < .001), fewer were diagnosed with recurrent AOM or AOM treatment failure (0.34 vs 1.6/child; P < .0001), and fewer had insertion of tympanostomy tubes (6.3% vs 14.8%) due to recurrent AOM (P < .0001). The combined direct payments and indirect costs for management of AOM were $539/case versus $1,023/control. Using Rochester NY payments generalized to the US birth cohort, this case diagnosis and treatment strategy could save $1.008 billion per year.
Introduction
The direct payments and indirect costs for management of otitis media in the United States during 1998 to 2008 have been estimated to exceed $5.3 to $6 billion annually. 1, 2 Included in direct payments are physician visits, antibiotics, and surgery for insertion of pressure equalizing tubes (PETs). Indirect costs include parent's lost work income, travel expenses, and forfeited day care costs. The 2004 AOM practice guidelines of the American Academy of Pediatrics (AAP) endorsed diagnostic criteria for acute otitis media (AOM) that did not require a full or bulging tympanic membrane (TM), 3 whereas the 2013 guideline did so. 4 The 2004 and 2013 AOM treatment guidelines endorsed amoxicillin, 80 to 100 mg/kg/day, as first-line antibiotic treatment and amoxicillin/clavulanate as second-line treatment. Since 1990 the authors of this article used a bulging TM to diagnose AOM, and they used amoxicillin/clavulanate as a first-line antibiotic since 2003 because tympanocentesis data in our practice show that amoxicillin would be unlikely to eradicate the otopathogens we identify. [5] [6] [7] Antibiotic consumption in pediatrics is an ongoing concern as a driver of antibiotic resistance among common bacterial pathogens. 8 AOM is the most common indication applied by pediatricians to prescribe antibiotics. 9 Insertion of PETs is the second most commonly performed surgery for children. 10 We postulated that stricter diagnostic criteria would reduce the frequency of AOM in practice; that antibiotic treatment directed at the most common otopathogens causing AOM in our community would result in fewer recurrent AOM and treatment failure cases; and that reductions in PET surgery would occur as a consequence of fewer recurrent AOM (rAOM) and AOM treatment failure (AOMTF) episodes. Here we describe an analysis of the costs of care for children diagnosed with AOM using bulging of the tympanic membrane (TM) as a requirement and treated first line with amoxicillin/ clavulanate (cases) compared to children diagnosed and treated according to the AAP 2004 AOM treatment guidelines (controls).
Methods

General Design
Cases were derived from a single private practice in suburban Rochester, NY, conducting an NIH National Institute of Deafness and Communication Disorderssponsored prospective, longitudinal study during the 5-year time span from July 2006 to July 2011. The physicians who enrolled and followed all cases were the authors (JC and MEP). Controls were derived from a different private practice in suburban Rochester, NY, enrolling children in the same study. Five pediatricians enrolled and followed all controls. All data were prospectively collected to document epidemiologic and risk factors for AOM, symptoms, and signs at the time of diagnosis of AOM and at follow-up. Enrollment of children occurred at age 6 months old and they were followed until 30 months old. Inclusion criteria were healthy, full-term birth, appropriate weight for age, upto-date with all vaccinations. Exclusion criteria were an AOM episode diagnosed prior to 6 months of age and any immunocompromised or anatomical defect that would make the child prone to AOM. The University of Rochester Medical Center and Rochester General Hospital Institutional Review Boards approved this study, and written informed consent was obtained from parents of all children enrolled.
Case to control matching included age and year of enrollment (to assure similar exposure to respiratory viruses and otopathogens circulating each season), gender, and race as epidemiologic variables. For AOM risk factors, matching included breast feeding for >6 months, day care attendance, and cigarette smoke exposure.
Definitions AOM Diagnostic Criteria. Cases diagnosed with AOM had recent, usually abrupt onset of symptoms of middle ear inflammation, presence of middle ear effusion (MEE), fullness/bulging of the TM, limited or absent mobility of the TM, and distinct erythema of the TM. Controls diagnosed with AOM had acute, usually abrupt onset of symptoms of middle ear inflammation, presence of MEE, and signs of acute middle ear inflammation as indicated by distinct bulging or limited or absent mobility of the TM or air-fluid levels behind the TM or distinct erythema of the TM. AOMTF was defined by the persistence of symptoms and signs of AOM beyond 48 hours after the start of antibiotic treatment or before 14 days had passed since diagnosis and a change in antibiotic therapy was instituted. 11, 12 rAOM was defined as an AOM occurring 15 to 30 days after a previous AOM. 11, 12 An AOM event was considered a new event, and referred to as a "simple" AOM episode if the child presented with an AOM >30 days after the preceding AOM. 3, 4 All children were scheduled for follow-up examination 3 weeks after diagnosis. Residual MEE was considered a normal finding at follow-up.
Treatment Regimen
Cases were empirically treated with high-dose amoxicillin/clavulanate (80-100 mg/kg/day divided BID) or cefdinir (14 mg/kg/day divided BID) for 5 days according to prior publications. 13, 14 Controls were empirically treated with amoxicillin (80-100 mg/kg/day divided BID) for 10 days or cefdinir (14 mg/kg/day QD) for 10 days. Cases received 3 doses of ceftriaxone (50 mg/kg/ dose) for any AOMTF or rAOM episodes. Controls received 10 days of high-dose amoxicillin/clavulanate or cefdinir (doses as above) for the first episode of AOMTF or rAOM. A second AOMTF or rAOM resulted in treatment with 2 to 3 doses of ceftriaxone (50 mg/kg/ dose).
Payment Analysis
We calculated costs for AOM management in the 2 groups using their respective treatment paradigms, the numbers of simple AOM episodes, rAOM and AOMTF episodes, and the numbers of children receiving PET surgery. All costs were taken from local Rochester, NY, payment rates provided by the 2 dominant HMOs in our community, which cover >80% of children. The average of payment from those 2 payers across the 5 years of the study was used to calculate actual cost of care to health insurers. To estimate parental time spent associated with visits we collected data on time away from work, travel distance, and time away from day care from a sample of 100 parents. For income we used the median income of Monroe County, NY, in 2010 obtained from the US Bureau of Labor Statistics.
Statistics
Comparisons between groups were accomplished with Student's t test, χ 2 test, and test of proportions as appropriate, and a P value <.05 was considered significant.
Results
Description of the Cohorts
There were 208 children in the case group and 1020 children in the control group. The groups were well matched. Mean age at enrollment was 5.8 months for cases and 5.9 months for controls. Eighty-eight percent of cases and 78% of controls were Caucasian; 56% and 52% were male; 34% and 28% were breast fed >6 months; 85% and 83% had no tobacco smoke exposure in the home; and 66% and 56% never attended day care. All were health-insured, and all were up-to-date with 7-valent or 13-valent pneumococcal conjugate vaccine (PCV7 or PCV13).
Forty-nine percent of case children and 69% of control children had at least 1 episode of AOM diagnosed between 6 and 30 months of age (Table 1 ). There were a total of 203 AOM episodes in 208 case children (0.98 episodes/child) compared to 2036 AOM episodes in 1020 children (1.99 episodes/child) among controls (P < .0001). The frequency of simple episodes of AOM, AOMTF, and rAOM for the 2 groups is shown in Table 1 . Sixteen (7.7%) of 208 case children experienced a total of 49 episodes compared to 316 (31%) of 1020 control children who experienced a total of 1120 episodes of rAOM (P < .0001). Fourteen (6.7%) of 208 children for a total of 22 episodes of AOMTF occurred in case children compared to 275 (27%) of 1020 control children for a total of 480 episodes of AOMTF (P < .0001). Altogether, rAOM or AOMTF occurred in 0.34 episodes/child in cases and 1.6 episodes/child in controls (P < .0001). Insertion of PETs due to rAOM or AOMTF occurred in 6.3% of case children and 14.8% of control children (P = .001).
Payment Saving Analysis
The payments of care and indirect costs in Rochester, NY, for diagnosis and management of AOM are shown in Table 2 . The indirect payments of time lost by parents to bring their child to the pediatric office varied widely because of timing in the day when suspicion of AOM occurred (eg, in the night or after parents had dropped their child at day care and had arrived at work and distance from the office and parent's home).
The direct payment and indirect cost for simple AOM episodes in case children was $283/child compared to $223/child in control children ( Table 3 ). The direct payment and indirect cost for first episodes of AOMTF or rAOM in case children was $645/child compared to $289/child in the control group (Table 3) . When control children had second and subsequent AOMTF or rAOM episodes the payment and indirect cost was $645/child. The indirect cost and payment for PET surgery incurred due to AOMTF or rAOM in 6.3% of case children and 14.8% of controls was $2221/child ( Table 3 ). The total payment of care and indirect cost per child in cases was $539 compared to $1,023 in controls ( Table 3 ). Table 2 allow generalization to other practices. Payment rates vary from one community to another. For example, the national average payment for insertion of tympanostomy tubes is $3584, 15 but in Rochester, NY, the payment is $1715. Oral antibiotic prices shown are for an average 10-day supply but prices in our community varied widely (Table 4 ). Prices for injection of ceftriaxone included payment for the drug and an administration fee of $12.00, although in Rochester, NY, an administration fee is not paid by the major insurers. Acoustic reflectometry was performed only for case children and billed in 12% of patient Mean is shown along with range of lost hours that mostly depended on whether AOM visit occurred after parent had gone to work and distance/time needed to bring child to office and return to work or home. The mean was used for all calculations in Table 3 . Time cost was based on $23.41/hour for hours lost and wage was taken from US National Bureau of Labor Statistics for all occupations, Monroe County, NY, 2010. The dollar amounts for antibiotic costs shown were derived by taking into account the frequency of prescription of the oral antibiotic in the group and the size of the bottle based on weight of the children.
The data shown in
encounters but was used more frequently without charge to assist in diagnosis. A low complexity (CPT 99212) visit is shown for follow-up visits but record review showed that compliance with a follow-up visit occurred in about 40% to 50% of cases for simple AOM and 60% to 70% of cases of AOMTF and rAOM. During rAOM and AOMTF visits, the use of amoxicillin/clavulanate and cefdinir differed between groups and is reflected in Table 3 . Three injections of ceftriaxone and an associated low complexity visit are included in the calculations when they were chosen as treatment but control children were treated with 2 injections in about 90% of cases.
Discussion
This is a novel, contemporary evaluation of the frequency of diagnosis of AOM, rAOM, and AOMTF and associated payments of care derived from a prospective, 5-year, longitudinal study. Uniquely, every AOM and its management were prospectively documented from 2 private pediatric practices in a single Upstate NY community. Cost of care was not taken from or derived from a large HMO or federal database. Instead, we captured the real payments and indirect costs from parent time lost for care from the specific patient group studied. The payment analysis shows that nearly a 50% difference in payment occurred in the care of the children studied by the 2 groups using differing diagnostic criteria and treatment paradigms for AOM. If the payments/ child and indirect costs calculated for controls versus cases were generalized to the US birth cohort, 16 using payments in Rochester, NY, an annual payment savings of $1.008 billion per year might occur ( Table 5 ). The reduction in antibiotic use and the ecological pressure that this might bring to young children would be an additional benefit.
When the strict requirement of a bulging TM was used as diagnostic criteria, 49% of children in the case group had at least 1 episode of AOM versus 69% of children in the control group using 2004 AAP diagnostic criteria. A difference of 20% in the diagnosis of AOM for every visit where symptoms compatible with AOM would result in more costs for management of AOM episodes due to more children reaching the threshold of rAOM and AOMTF and possibly leading to tympanostomy tube surgery.
The contribution of differences in diagnostic criteria application and differences attributable to the diagnostician cannot be determined in this study. All the pediatricians were board-certified and received residency training in the United States.
Antibiotic treatment regimens differed. Control treatment was based on guideline recommendations while case treatment was based on the otopathogen mix and the antibiotic susceptibility of those bacteria determined by tympanocentesis routinely performed. [5] [6] [7] Physicians treating control children varied in their use of cefdinir predominantly based on their impressions of poor tolerability with amoxicillin/clavulanate. 17 Case children The dollar amounts for antibiotic costs shown were derived by taking into account the frequency of prescription of the oral antibiotic in the group and the size of the bottle based on weight of the children.
were treated with cefdinir less frequently because amoxicillin/clavulanate is more efficacious. 18 Control children were treated with 2 injections of ceftriaxone for recurrent AOM or AOMTF while case children received 3 injections on 3 separate visits. 19 The reintroduction of tympanocentesis into routine pediatric practice is unlikely to occur. However, our previous publication regarding individualized care of children with AOM an intervention group had tympanocentesis for all AOM episodes. 20 We did a payment analysis of the individualized treatment paradigm and the payment was calculated to be $466/child (Tables 6 and 7) .
Control group outcomes reported here match closely the results of a prior study involving pediatric and family medicine practices in Rochester, NY, and the State of Tennessee. 21 Therefore, we consider the care rendered to control children as representative of pediatricians and family physicians in our community in general. The frequency of children reaching the definition threshold of rAOM among controls was 31% and for the entire Rochester community study it was 21%.
In 1997, Byrns et al examined utilization of services for otitis media by children enrolled in Medicaid in Colorado. 22 They found the average number of ambulatory visits per child for otitis media was 2.2, 3.0, and 2.5 for those ages <1year, 1 to 2 years, and 2 to 3 years, respectively. Surgical procedures were performed in 5.4/100 children. They also found that 29.9% of children who had tympanostomy tube surgery went on to receive an adenoidectomy with or without a concurrent tonsillectomy by age 6 years. Using claims data from a large New England health insurer, in 1999, Thompson et al 23 reported that children averaged 2.9 physician office visits for management of otitis media; among children <2 years old, 25% had 6 or more such visits. A total of 4.6% of children <2 years of age had an otitis media-related surgical procedure. In a study of costs of otitis media in a managed care population in Northern California in 1997, average costs of simple and complex episodes of otitis media in children <14 years old were calculated. 24 A complex episode was defined similar to our study definition of rAOM and AOMTF. Interviews were conducted to establish work loss related to AOM care. The average number of work hours lost in the Northern California population was 5.9 and was assigned a cost of $120. They also tallied costs of days missed from prepaid day care, extra babysitting, travel-related expenses, co-payments, and over-thecounter medications and assigned those costs an average of $13/family. Of the total medical costs, outpatient visits comprised $6.28 million (78%), hospitalizations comprised $1.08 million (14%) and antimicrobial treatments comprised 0.66 million (8% There are limitations to this study. The prospective enrollment of children was with the intent of studying pathogenesis and immune responses to AOM, not diagnosis and treatment differences of AOM. Therefore, the study was neither randomized nor investigator-blinded. However, this analysis occurred after prospective enrollment of children. All AOM events and surgeries were documented in the medical record. Control children were matched 5:1 for the age and month of enrollment of case child. Therefore, bias from lack of randomization or investigator blinding is lessened. The ecological impact of overdiagnosis leading to unnecessary use of antibiotics was not assessed. The number of days that children had middle ear effusion was not studied. Data on the use of symptomatic pain relief medication prescribed or used was not collected. We did not capture several payments and consequences associated with care of AOM. Children who have one set of tubes are the most likely to receive more tube surgery. 27 About 50% of the children who had tympanostomy tube surgery went on to receive a second set of tubes and about 10% went on to have an adenoidectomy/tonsillectomy, similar to a previous study. 22 Some children require surgery to remove tympanostomy tubes. Data on complications from receiving antibiotics was not captured. The impact on QALYs was not calculated. 2 In conclusion, this study shows that using a bulging TM as a strict requirement for diagnosing AOM in young children would be payment effective. Moreover, the ecological benefit and financial savings from less frequent use of antibiotic therapy for AOM could be substantial.
